Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi

Executive Summary

Firm's "power brands" in respiratory and pain areas achieved high single-digit sales growth in the fourth quarter on an “earlier and more severe” cold season that also drove overall consumer health sales in the period up 4.3% to $2.65bn.


Related Content

GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
Walmsley: GSK Is 'Prepared' And 'Ready' For US Advair Generic Launch
Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Consumer Business Reliable And Right At Home At GlaxoSmithKline
Glaxo’s Parodontax Brings Bleeding Gums Claim To US Toothpaste Battle
GSK Aims Flonase Sensimist To Counter Generic Nasal Allergy Competition
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
Fluticasone Spray Competition Grows With Perrigo Launch Of West-Ward Product


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts